Research Article
Systemic Lupus Erythematosus, Its Impact on Selected Cardiovascular Risk Factors, and Correlation with Duration of Illness: A Pilot Study
Table 1
Anthropometric characteristics, SLEDAI-2K, and lipid profile of control and study groups.
| | Patient characteristics | Study group | Control group | value |
| | Age (years) | 56.45 ± 11.01 | 51.91 ± 12.38 | 0.3212 | | Female (%) (n) | 89.94 (34) | 90.47 (19) | 0.8122 | | Height (cm) | 161.59 ± 18.44 | 163.60 ± 6.84 | 0.6757 | | Weight (kg) | 72.05 ± 16.01 | 73.09 ± 16.43 | 0.7235 | | BMI (kg/m2) | 26.61 ± 4.59 | 27.26 ± 4.71 | 0.6159 | | Smokers (%) (n) | 18.42 (7) | 4 (1) | 0.3174 | | SLEDAI-2K | 6.89 ± 5.51 | — | — | | SLEDAI-2K >6 | 44.74 (17) | — | — | | Disease duration (years) | 10.21 ± 7.69 | — | — | | Time of treatment (years) | 10.21 ± 7.69 | — | — | | Lipid profile | | TC (mg/dl) | 205.74 ± 47.83 | 195.33 ± 53.31 | 0.4622 | | HDL (mg/dl) | 64.55 ± 18.76 | 67.55 ± 13.65 | 0.8122 | | LDL (mg/dl) | 118.41 ± 43.62 | 113.60 ± 43.92 | 0.6898 | | TG (mg/dl) | 114.09 ± 35.89 | 94.53 ± 41.63 | 0.1806 |
|
|
BMI : body mass index; SLEDAI-2K : Systemic Lupus Erythematosus Disease Activity Index; TC : total cholesterol; HDL : high-density cholesterol; LDL : low-density cholesterol; TG : triglycerides. Source: own studies.
|
